Orchid Pharma Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding the availability of an audio recording from its earnings call with analysts and investors.
The disclosure is made pursuant to Regulation 30, Subpara 15 of Para A Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. It also references SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
This communication serves as a continuation of earlier intimations dated May 19, 2026, and May 26, 2026, related to the Analysts/Investors Earnings Call.
The earnings call was held on May 26, 2026, at 04:30 P.M. Indian Standard Time (IST). The company confirms that the call was conducted through an audio conference call format, and specifically notes that no video recording is available for this event.
The audio recording has been made available for access at the following link: https://www.orchidpharma.com/downloads/10043525.mp3
The disclosure is signed by Kapil Dayya, who holds the positions of Company Secretary and Compliance Officer (Membership Number: F10698). The document was digitally signed on May 26, 2026, at 19:31:40 IST.